Inhibitors of Monoamine Oxidase B: Pharmacology and Clinical Use in Neurodegenerative Disorders (Milestones in Drug Therapy) (German Edition) download epub
Authors: SZELENYI, ISTVAN. Pharmacology of Monoamine Oxidase Type B Inhibitors.
Authors: SZELENYI, ISTVAN. The Pharmacological Basis of the Therapeutic Effect of (-)-Deprenyl in Age-Related Neurological Diseases. Neurotoxins and Monoamine Oxidase B Inhibitors: Possible Mechanisms for the Neuroprotective Effect of (-)-Deprenyl.
ae at best prices Usually ships within 4 to 5 days. by Szelenyi (Author), Istvan (Author). ISBN-13: 978-3034863490.
Usually ships within 4 to 5 days.
Expert opinion: Antidepressant drugs increase synaptic concentrations of biogenic amines.
Series: Milestones in Drug Therapy. Other readers will always be interested in your opinion of the books you've read. Whether you've loved the book or not, if you give your honest and detailed thoughts then people will find new books that are right for them. File: PDF, 3. 1 MB. Save for later.
Tell us if something is incorrect. Milestones in Drug Therapy. Birkhauser, Birkhauser Basel. We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here, and we have not verified it. See our disclaimer Inhibitors of Monoamine Oxidase B. Specifications.
Inhibitors of Monoamine . .has been added to your Cart.
Inhibitors of Monoamine Oxidase B book.
PDF Traditional monoamine oxidase inhibitors (MAOIs) have long been associated with tyramine-related hypertension-the cheese effect. Despite their undoubted clinical efficacy, this problem has restricted their use. Cite this publication.
Isolated monoamine oxidase B deficiency has not yet been reported in a patient. Two brothers with a microdeletion, including the Norrie locus and monoamine oxidase B, however, had features consistent with Norrie disease alone. The interactions between MAO inhibitors and drugs commonly used in anesthesia have been well described. Although genetic polymorphisms in MAO genes exist and are of great interest in the fields of neurology and psychiatry, to date none have been identified that specifically concern the handling of anesthetic agents.
Monoamine oxidase inhibitors (MAOIs) are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). They are particularly effective in treatment-resistant depression and atypical depression.